Track Sinopharm Group Co., Ltd. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Sinopharm Group Co., Ltd. 1099.HK Open Sinopharm Group Co., Ltd. in new tab

20.92 HKD
P/E
7.82
EPS
2.60
Yield
3.49%
Safety Score
77
P/B
0.68
Beta
0.62
Target Price
22.79 HKD
Loading chart...
Key Metrics
Earnings dateApril 23, 2026
P/E7.82
EPS2.60
Book Value29.84
Price to Book0.68
Debt/Equity63.00
Growth
Revenue Growth-0.02%
Earnings Growth5.48%
Estimates
Forward P/E6.64
Forward EPS3.06
Target Mean Price22.79
Dividend
Dividend Yield3.49%
Annual dividends0.65 HKD
Ex-Div. DateJune 23, 2026
Payout71.41%
5y avg Yield4.33%

DCF Valuation

Tweak assumptions to recompute fair value for Sinopharm Group Co., Ltd. (1099.HK)
Currency: HKD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Sinopharm Group Co., Ltd. Logo Sinopharm Group Co., Ltd. Analysis (1099.HK)

China Health Care Official Website Stock

Is Sinopharm Group Co., Ltd. a good investment? Sinopharm Group Co., Ltd. (1099.HK) is currently trading at 20.92 HKD. Market analysts have a consensus price target of 22.79 HKD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 7.82. This relatively low multiple may signal that Sinopharm Group Co., Ltd. is undervalued compared to historical market norms.

Earnings Schedule: Sinopharm Group Co., Ltd. is expected to release its next earnings report on April 23, 2026. The market consensus estimate for Forward EPS is 3.06.

For income investors, Sinopharm Group Co., Ltd. pays a dividend yield of 3.49%. With a payout ratio of 71%, the dividend appears sustainable.

Investor FAQ

Does Sinopharm Group Co., Ltd. pay a dividend?

Yes, it pays an annual dividend of 0.65 HKD (3.49% yield).

What asset class is Sinopharm Group Co., Ltd.?

Sinopharm Group Co., Ltd. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be April 23, 2026. The company currently has a trailing EPS of 2.60.

Company Profile

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Exchange Ticker
HKG (Hong Kong) 1099.HK
PNK (United States) SHTDF
Dividend Yield

3.49% (5y avg: 4.33%)

Annual Dividends

0.65 HKD

Next ex. div date

June 23, 2026

Payout Ratio

71.41%

Historical Dividends
Year Total Dividends
2026 0.78 HKD
2025 0.74 HKD
2024 0.96 HKD
2023 0.90 HKD
2022 0.87 HKD
2021 0.84 HKD
2020 0.65 HKD
2019 0.67 HKD
2018 0.69 HKD
2017 0.57 HKD
2016 0.48 HKD
2015 0.31 HKD
2014 0.26 HKD
2013 0.25 HKD
2012 0.19 HKD
2011 0.16 HKD
2010 0.01 HKD

Yearly aggregated dividends

Dividends

Sinopharm Group Co., Ltd.
Aug 18, 2026 Upcoming
Dividend
0.78287 HKD
Sinopharm Group Co., Ltd.
Aug 12, 2025 Paid
Dividend
0.739 HKD

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion